These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7835196)

  • 1. Levocabastine eye drops in the treatment of vernal conjunctivitis.
    Goes F; Blockhuys S; Janssens M
    Doc Ophthalmol; 1994; 87(3):271-81. PubMed ID: 7835196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
    Giede C; Metzenauer P; Petzold U; Ellers-Lenz B
    Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
    Azevedo M; Castel-Branco MG; Oliveira JF; Ramos E; Delgado L; Almeida J
    Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children.
    Sabbah A; Marzetto M
    Curr Med Res Opin; 1998; 14(3):161-70. PubMed ID: 9787982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid onset of action of levocabastine eye-drops in histamine-induced conjunctivitis.
    Stokes TC; Feinberg G
    Clin Exp Allergy; 1993 Sep; 23(9):791-4. PubMed ID: 10779311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
    Verin P; Easty DL; Secchi A; Ciprandi G; Partouche P; Nemeth-Wasmer G; Brancato R; Harrisberg CJ; Estivin-Ebrardt C; Coster DJ; Apel AJ; Coroneo MT; Knorr M; Carmichael TR; Kent-Smith BT; Abrantes P; Leonardi A; Cerqueti PM; Modorati G; Martinez M
    Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis.
    Davies BH; Mullins J
    Allergy; 1993 Oct; 48(7):519-24. PubMed ID: 7902022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team.
    Allergy; 1994 Sep; 49(8):611-5. PubMed ID: 7653738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of topical levocabastine compared with oral terfenadine.
    Bahmer FA; Ruprecht KW
    Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New trends in the treatment of allergic conjunctivitis.
    Parys W; Blockhuys S; Janssens M
    Doc Ophthalmol; 1992; 82(4):353-60. PubMed ID: 1363981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis.
    Abelson MB; Weintraub D
    Eur J Ophthalmol; 1994; 4(2):91-101. PubMed ID: 7950341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of levocabastine eye drops.
    Janssens M; Blockhuys S
    Doc Ophthalmol; 1993; 84(2):111-8. PubMed ID: 7905376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects levocabastine ophthalmic solution (H1 receptor antagonist) on symptoms of vernal conjunctivitis. A prospective, randomized double-blind study].
    Graue E
    Gac Med Mex; 1994; 130(6):481-6. PubMed ID: 7557064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
    Vermeulen J; Mercer M
    Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P; Allewaert R; Joyaux JC; Piozzi E; Koliopoulos J; Bloch-Michel E;
    Eur J Ophthalmol; 2001; 11(2):120-5. PubMed ID: 11456011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind evaluation of topical levocabastine, a new specific H1 antagonist in patients with allergic conjunctivitis.
    Pipkorn U; Bende M; Hedner J; Hedner T
    Allergy; 1985 Oct; 40(7):491-6. PubMed ID: 2866725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitis.
    Abelson MB; George MA; Schaefer K; Smith LM
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):458-64. PubMed ID: 7916020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S; McTavish D
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis.
    Ciprandi G; Cerqueti PM; Sacca S; Cilli P; Canonica GW
    Ann Allergy; 1990 Aug; 65(2):156-8. PubMed ID: 1974402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.